UCB's Global Corporate Website
Welcome to UCB in the United States

Jun

08

Employee Spotlight: Natasha Trujillo’s Passion for Advocacy

Jun

02

Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome

Jun

01

Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

May

08

Celebrating Asian American and Pacific Islander Heritage Month with our ACES Employee Resource Group

Apr

27

Voices on Value: Breaking Down the Value Chain: The Policies Impacting Patients

Apr

26

Employee Spotlight: Debbie Smith’s Journey on Moving the Conversation Forward in Epilepsy and Health Equity

Apr

21

Earth Day 2023: Our Commitment to Sustainability in the Workplace

Apr

20

UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting

Apr

18

How Shared Decision-Making Creates Better Patient-Provider Collaboration in Dermatology

Apr

17

UCB Announces FINTEPLA® (fenfluramine) Oral Solution Is Now Descheduled and Is No Longer Listed as a Controlled Substance